Contribute Try STAT+ Today My Account

diabetes

Most Read

Blood sugar monitor - finger stick

Biotech By Jonathan Chan

A Chinese drug maker scores a big clinical trial win with a novel diabetes therapy

FDA-Blood Sugar Monitor

Health By Associated Press

FDA approves first blood sugar monitor without finger pricks

Living Longer

First Opinion By Jane Barratt

We are living longer than ever. But are we living better?

Dr. Valter Longo

Health By Usha Lee McFarling

He wants to sell you a $300 ‘fasting diet’ to prolong your life. It might not be as crazy as it sounds

Stark medication bottle

Pharmalot By Ed Silverman

FDA petitioned to recall batches of metformin diabetes pill over a possible carcinogen

Blood sugar monitor - finger stick

First Opinion By Lorena Alarcon-Casas Wright

Time in range: a new way for people with diabetes to monitor blood sugar

Pharmalot By Ed Silverman

Pharmalittle: U.S. Chamber wants transparency around Covid-19 vaccines; EU to pump billions into vaccine deals

Blood glucose monitor

First Opinion By Camillo Ricordi and Anthony Japour

Transplanting islet cells can fix brittle diabetes. Why isn’t it available in the U.S.?

All Coverage

Election 2020 First Debate

Politics By Nicholas Florko

Trump claims his policies made insulin ‘so cheap, it’s like water.’ But for most people, it costs just as much as before

Insulin in Minnesota

Politics By Nicholas Florko

Drug makers sue to block Minnesota law making it cheaper to get insulin in emergencies

advertisement

crashing wave

Health By Meghana Keshavan

As wave of Covid-19 cases crashes, a surge in other health conditions looms

Pharmalot By Ed Silverman

Pharmalittle: WHO sets goals for distributing Covid-19 treatments; new warnings urged on diabetes drugs

Pharmalot By Ed Silverman

Pharmalittle: Glaxo aims for 1 billion doses of a Covid-19 vaccine booster; Pence aide holds lots of pharma stocks

Truemann Mills 7

Health Tech By Casey Ross

In fading steel towns, chronically ill patients hope video visits stay after the pandemic goes

Nicole Smith-Holt

Politics By Nicholas Florko

After a hard-won political fight, this state expanded access to insulin. Can others follow its lead?

Novo Nordisk Denmark

Pharmalot By Ed Silverman

Novo Nordisk becomes latest insulin maker seeking to foster goodwill amid Covid-19

Medical office closed

Health Tech By Erin Brodwin

With Covid-19 delaying routine care, chronic disease startups brace for a slew of complications

insulin syringes

Politics By Nicholas Florko

Will Trump’s new plan to cap insulin costs in Medicare actually save seniors much money? It’s complicated

FDA through the window

Biotech By Kate Sheridan

FDA rejects Intarcia’s diabetes implant for a second time

Emma Klek - TD1 journey

Health By Nicholas Florko

See one woman’s complicated, costly journey to a Canadian strip mall pharmacy — all for cheaper insulin

Chuck Grassley

Politics By STAT staff

Sen. Chuck Grassley takes your questions on drug prices, insulin, and innovation

Electrocardiogram readout

Pharmalot By Ed Silverman

Years later, raw clinical trial data tells us the extent of Avandia’s heart risks

Wide shot insulin protest Cambridge

Politics By Nicholas Florko

More than a dozen Democrats are bringing people with sky-high insulin bills to the State of the Union

Janelle Lutgen

Health By Lev Facher

It’s the insulin, stupid: How drug pricing’s simplest case study became a top issue for 2020 Democrats

Dr. Vivian Lee

Health Tech By Erin Brodwin and Matthew Herper

Verily’s top health leaders: We’re ‘trying to solve problems that many of us have lived’

Eli Lilly insulin

Pharmalot By Ed Silverman

Lilly exec says ‘there are no villains’ in the high-priced insulin market

headquarters of Verily Life Sciences

Exclusive By Erin Brodwin

Verily tangos at JPM with a health tech partner — and steps on a few toes

Dexcom G6 Receiver

Health Tech By Rebecca Robbins

Eyeing more data, Livongo will integrate continuous glucose monitor into diabetes coaching program

Insulin NOVO NORDISK

Pharmalot By Ed Silverman

Lawmakers say a Lilly program to offer half-price insulin is a bust

Blood sugar monitor - finger stick

Health Tech By Rebecca Robbins

What Sanofi’s withdrawal from diabetes tech tells us about digital health

Smartphone in the dark

Health Tech By Matthew Herper

A glitch in diabetes monitors serves as a cautionary tale for health tech

Insulin Pens

First Opinion By John LaMattina

Today’s insulin isn’t what Banting and Best developed. It’s far, far better

Health coaches

Health Tech By Rebecca Robbins

Valued for their tech, Silicon Valley digital health companies rely heavily on armies of faraway coaches